Drawing from implementation lessons and successes in other industries, possible strategy shifts to pharma’s pricing playbook are explored.
Juan F. Rivera
Advertisement
Articles by Juan F. Rivera
Advertisement
Latest Updated Articles
Pricing Turning Point: The Case for Innovating Pharma’s ModelPublished: March 6th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
2
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
3
Join Us Tonight: Inside Trump’s Drug Price Plan
4
Roundup: Biotech’s Most Recent Strategic Partnerships and Exclusive Licensing Agreements
5
